Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
J Med Internet Res. 2023 May 24;25:e41283. doi: 10.2196/41283.
Obsessive-compulsive disorder (OCD) is a common and chronic mental illness with a high rate of disability. Internet-based cognitive behavioral therapy (ICBT) makes online treatment available to patients and has been shown to be effective. However, 3-arm trials on ICBT, face-to-face cognitive behavioral group therapy (CBGT), and only medication are still lacking.
This study is a randomized, controlled, assessor-blinded trial of 3 groups for OCD: ICBT combined with medication, CBGT combined with medication, and conventional medical treatment (ie, treatment as usual [TAU]). The study aims to investigate the efficacy and cost-effectiveness of ICBT related to CBGT and TAU for adults with OCD in China.
In total, 99 patients with OCD were selected and randomly assigned to the ICBT, CBGT, and TAU groups for treatment for 6 weeks. The primary outcomes were the Yale-Brown Obsessive-Compulsive Scale (YBOCS) and the self-rating Florida Obsessive-Compulsive Inventory (FOCI), compared at baseline, during treatment (3 weeks), and after treatment (6 weeks), to analyze efficacy. The secondary outcome was the EuroQol Visual Analogue Scale (EQ-VAS) scores of the EuroQol 5D Questionnaire (EQ-5D). The cost questionnaires were recorded to analyze cost-effectiveness.
Repeated-measures ANOVA was used for data analysis, and the final effective sample size was 93 (ICBT: n=32, 34.4%; CBGT: n=28, 30.1%; TAU: n=33, 35.5%). After 6-week treatment, the YBOCS scores of the 3 groups significantly decreased (P<.001), and there were no significant differences among groups. The FOCI score of the ICBT (P=.001) and CBGT (P=.035) groups was significantly lower than that of the TAU group after treatment. The total cost of the CBGT group (renminbi [RMB] 6678.45, 95% CI 4460.88-8896.01 [US $1010.36, 95% CI 678.87-1345.84]) was significantly higher than that of the ICBT group (RMB 3308.81, 95% CI 2476.89-4140.73[US $500.58, 95% CI 374.72-626.43], P<.001) and the TAU group (RMB 2259.61, 95% CI 2074.16-2445.05 [US $341.85, 95% CI 313.79-369.90], P<.001) after treatment. The ICBT group spent RMB 303.19 (US $45.97) less than the CBGT group and RMB 11.57 (US $1.75) less than the TAU group for each unit reduction in the YBOCS score.
Therapist-guided ICBT combined with medication is as effective as face-to-face CBGT combined with medication for OCD. ICBT combined with medication is more cost-effective than CBGT combined with medication and conventional medical treatment. It is expected to become an efficacious and economic alternative for adults with OCD when face-to-face CBGT is not available.
Chinese Clinical Trial Registry ChiCTR1900023840; https://www.chictr.org.cn/showproj.html?proj=39294.
强迫症(OCD)是一种常见且慢性的精神疾病,致残率较高。基于互联网的认知行为疗法(ICBT)使在线治疗成为可能,并已被证明是有效的。然而,针对 ICBT、面对面认知行为团体治疗(CBGT)和仅药物治疗的三臂试验仍然缺乏。
本研究是一项针对 OCD 的随机、对照、评估者盲法试验,分为 3 组:ICBT 联合药物治疗、CBGT 联合药物治疗和常规药物治疗(即治疗即常规[TAU])。该研究旨在探讨 ICBT 与 CBGT 和 TAU 相关治疗在中国 OCD 成人患者中的疗效和成本效益。
共选择了 99 名 OCD 患者,并随机分配到 ICBT、CBGT 和 TAU 组进行治疗,为期 6 周。主要结局是耶鲁-布朗强迫症量表(YBOCS)和自我评定佛罗里达强迫症量表(FOCI),分别在基线、治疗期间(3 周)和治疗后(6 周)进行评估,以分析疗效。次要结局是 EuroQol 5 维问卷(EQ-5D)的 EuroQol 视觉模拟量表(EQ-VAS)评分。记录成本问卷以分析成本效益。
采用重复测量方差分析进行数据分析,最终有效样本量为 93 例(ICBT:n=32,34.4%;CBGT:n=28,30.1%;TAU:n=33,35.5%)。经过 6 周治疗,3 组的 YBOCS 评分均显著降低(P<.001),且组间无显著差异。治疗后,ICBT(P=.001)和 CBGT(P=.035)组的 FOCI 评分明显低于 TAU 组。CBGT 组的总成本(人民币 6678.45 元,95%置信区间 4460.88-8896.01[美元 1010.36,95%置信区间 678.87-1345.84])明显高于 ICBT 组(人民币 3308.81 元,95%置信区间 2476.89-4140.73[美元 500.58,95%置信区间 374.72-626.43])和 TAU 组(人民币 2259.61 元,95%置信区间 2074.16-2445.05[美元 341.85,95%置信区间 313.79-369.90]),治疗后差异有统计学意义(P<.001)。ICBT 组在 YBOCS 评分每降低 1 分的情况下,比 CBGT 组节省人民币 303.19 元(50.97 美元),比 TAU 组节省人民币 11.57 元(1.75 美元)。
治疗师指导的 ICBT 联合药物治疗与面对面的 CBGT 联合药物治疗对 OCD 同样有效。ICBT 联合药物治疗比 CBGT 联合药物治疗和常规药物治疗更具成本效益。当面对面的 CBGT 不可用时,预计它将成为 OCD 成人患者一种有效且经济的替代治疗方法。
中国临床试验注册中心 ChiCTR1900023840;https://www.chictr.org.cn/showproj.html?proj=39294。